The US Dollars $4,452,206 was re-allocated from the HIV grant from the savings on the Procurement Costs incurred on health commodities in Uganda’s current HIV Grant (UGA-H-MoFPED). This support from the Global Fund was used to support the following Covid-19 Emergency Preparedness and Response Plan interventions: Procurement of...
Find here our calendar of events and activities for 2020 Download PDF
The COVID-19 pandemic is having a catastrophic impact on the most vulnerable communities worldwide and threatens progress in the fight against Malaria, HIV and Tuberculosis. In the lead-up to this year’s World Malaria Day, countries across the globe are in the throes of responding...
FOR THE IMPLEMENTATION PERIOD 1st JANUARY 2021 TO 31st DECEMBER 2023 Eligible Disease Component Allocation (US Dollars $) Allocation Utilization/Grant Implementation Period HIV $289,203,023 1 January 2021 to 31 December 2023 Tuberculosis $29,773,958 1 January 2021 to 31 December 2023 Malaria $260,024,950 1 January 2021 to...
The Uganda CCM successfully submits Uganda’s HIV/TB and Malaria grants for the Global Fund 2020-2022 allocation period. Uganda also applied US Dollars $24.5 million for in Catalytic Matching Funds. The Uganda CCM prepared Uganda’s Global Fund grant applications for the implementation period 2021-2023. Based...
TASO has displayed the Best Evaluated Bidder Notice from the selection of Sub-Recipients for Implementation of Global Fund HIV/TB and Malaria grants for the period 2018/2020. This Notice is on display for 5 working days from 20th to 26th September 2018. Further details of...
A massive thanks to all the country partners that attended/ supported Uganda’s malaria TB/HIV and Resilient and Sustainable Systems for Health Grant signing event at Hotel Africana for the year 2018.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Phasellus a nunc imperdiet, bibendum lectus accumsan, aliquet nisl. Fusce a venenatis diam.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Phasellus a nunc imperdiet, bibendum lectus accumsan, aliquet nisl. Fusce a venenatis diam.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Phasellus a nunc imperdiet, bibendum lectus accumsan, aliquet nisl. Fusce a venenatis diam.

